Literature DB >> 19802996

Pharmacokinetics of ceftazidime in normal subjects.

S M Harding1, J Ayrton, J E Thornton, A J Munro, M I Hogg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 19802996     DOI： 10.1093/jac/8.suppl_b.261

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

1.  Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.

Authors:  A Hedman; Y Adan-Abdi; G Alvan; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

2.  Pharmacokinetics and tissue concentrations of ceftazidime in burn patients.

Authors:  R A Walstad; L Aanderud; E Thurmann-Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Influence of probenecid on serum and subcutaneous tissue fluid concentrations of benzylpenicillin and ceftazidime in human volunteers.

Authors:  B Hoffstedt; S Haidl; M Walder
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

4.  Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients.

Authors:  M Jonsson; M Walder
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

5.  The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.

Authors:  R A Walstad; K Dahl; K B Hellum; E Thurmann-Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

7.  Altered pharmacokinetics of ceftazidime in critically ill patients.

Authors:  C M Gómez; J J Cordingly; M G Palazzo
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

8.  Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.

Authors:  Christophe Mariat; Christophe Venet; François Jehl; Sandrine Mwewa; Vesna Lazarevic; Eric Diconne; Nathalie Fonsale; Anne Carricajo; Stéphane Guyomarc'h; Régine Vermesch; Gérald Aubert; Roselyne Bidault; Jean-Claude Bertrand; Fabrice Zeni
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

Review 9.  Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations.

Authors:  Antonio Torres; Johan Willem Mouton; Federico Pea
Journal:  Clin Pharmacokinet       Date:  2016-12       Impact factor: 6.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.